Eli Lilly investors are eager for Foundayo insight after early launch data
By Chris Prentice and Mariam Sunny
April 29 (Reuters) - Eli Lilly investors will be searching for something they won't find in any first-quarter financial figures reported on Thursday: insight into the launch of weight-loss pill Foundayo.
U.S. sales of the hotly anticipated obesity offering, a... Read More.


